{"archive_url":"http://www.ebi.ac.uk/ena/data/view/ERX297408","experiment":{"EXPERIMENT_TYPE":"Histone H3K4me3","EXPERIMENT_ID":"ERX297408","attributes":{"EXTRACTION_PROTOCOL_SONICATION_CYCLES":["3x 10 min; 30 sec ON/ 30 sec OFF"],"CHIP_ANTIBODY":["H3K4me3"],"CHIP_PROTOCOL_BEAD_TYPE":["magnetic beads A and G"],"CHIP_ANTIBODY_CATALOG":["pAb-003-050"],"CHIP_PROTOCOL_BEAD_AMOUNT":["20 ?l"],"EXPERIMENT_TYPE":["Histone H3K4me3"],"CHIP_PROTOCOL_ANTIBODY_AMOUNT":["1,0 ?g"],"CHIP_ANTIBODY_LOT":["A5051-001P"],"CHIP_PROTOCOL_CHROMATIN_AMOUNT":["5x 100.000 cells = 5x 6,7 ?l"],"EXTRACTION_PROTOCOL":["Chromatin was extracted using the histone protocol. Cells are crosslinked 10 min in 1% formaldehyde. Washed twice in PBS and dissolved in shearing buffer (containing 1% SDS), such that the final concentration is 15*10^6 cells/ml."],"CHIP_PROTOCOL":["Transcription factor protocol: 100.000 cells per ChIP (5x) and pool at the end. Overnight incubation of chromatin with antibody and A/G magnetic beads. Wash twice with buffer 1, once with buffer 2 and 3 and twice with buffer 4 at 4 degrees. Elute 20 min with elution buffer at RT. Descrosslink 4 hours at 65 degrees. Purify by column purification."],"CHIP_ANTIBODY_PROVIDER":["Diagenode"],"EXTRACTION_PROTOCOL_TYPE_OF_SONICATOR":["Bioruptor Plus (UCD-300)"]},"ASSAY_TYPE":"ChIP-Seq"},"archive":"ENA","ftp_path":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/Cell_Line/BL-2/Sporadic_Burkitt_lymphoma/ChIP-Seq/NCMLS","files":[{"FORMAT":"bigBed","SIZE":"1.1M","NAME":"BL-2_c01.ERX297408.H3K4me3.bwa.GRCh38.20150527.bb","FILE_TYPE":"CHIP_MACS2_BB","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/Cell_Line/BL-2/Sporadic_Burkitt_lymphoma/ChIP-Seq/NCMLS/BL-2_c01.ERX297408.H3K4me3.bwa.GRCh38.20150527.bb","PROTOCOL_DOC":"chip_seq_grch38","MD5":"ae8082d634e1afd5e0d330d5025d9987"},{"FORMAT":"BED","SIZE":"1.4M","NAME":"BL-2_c01.ERX297408.H3K4me3.bwa.GRCh38.20150527.bed.gz","FILE_TYPE":"CHIP_MACS2_BED","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/Cell_Line/BL-2/Sporadic_Burkitt_lymphoma/ChIP-Seq/NCMLS/BL-2_c01.ERX297408.H3K4me3.bwa.GRCh38.20150527.bed.gz","PROTOCOL_DOC":"chip_seq_grch38","MD5":"a23aa8a022543810929601913250f02d"},{"FORMAT":"Text","SIZE":"1.6M","NAME":"BL-2_c01.ERX297408.H3K4me3.bwa.GRCh38.20150527.xls.gz","FILE_TYPE":"CHIP_MACS2_BED","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/Cell_Line/BL-2/Sporadic_Burkitt_lymphoma/ChIP-Seq/NCMLS/BL-2_c01.ERX297408.H3K4me3.bwa.GRCh38.20150527.xls.gz","PROTOCOL_DOC":"chip_seq_grch38","MD5":"b4c23a3609fe56f97e215f9a7b5dcdf5"},{"FORMAT":"bigWig","SIZE":"631M","NAME":"BL-2_c01.ERX297408.H3K4me3.bwa.GRCh38.20150528.bw","FILE_TYPE":"CHIP_WIGGLER","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Normalized signal","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/Cell_Line/BL-2/Sporadic_Burkitt_lymphoma/ChIP-Seq/NCMLS/BL-2_c01.ERX297408.H3K4me3.bwa.GRCh38.20150528.bw","PROTOCOL_DOC":"chip_seq_grch38","MD5":"4377b5f7cf750d899b090793aeb4ee4c"}],"sample":{"SAMPLE_SOURCE":"Cell Line","SAMPLE_NAME":"BL-2","sample_barcode":"BL-2_c01","attributes":{"DIFFERENTIATION_METHOD":["Drexler HG chapter 16 Establishment and culture of leukemia-lymphoma cell in Cancer Cell Culture Methods and Protocols 2nd Edition Springer Berlin pp 181 to 200 in 2011"],"MOLECULE":["genomic DNA"],"DISEASE":["Sporadic Burkitt lymphoma"],"LINEAGE":["NA"],"BATCH":["NA"],"BIOMATERIAL_PROVIDER":["DSMZ"],"BIOMATERIAL_TYPE":["Cell Line"],"DISEASE_ONTOLOGY_URI":[{"url":"7","label":"C1336077"}],"SAMPLE_ONTOLOGY_URI":[{"url":"5","label":"EFO_0005475"}],"SEX":["Male"],"PASSAGE":["NA"],"DIFFERENTIATION_STAGE":["B cell"],"MEDIUM":["RPMI 1640 + 10%FBS + 1% Glutamine"],"LINE":["BL-2"]},"SAMPLE_ID":"ERS333897","SAMPLE_DESCRIPTION":"Sporadic Burkitt lymphoma"}}